Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16051 - 16075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	CHRM4	1132	downregulated	Carmustine results in decreased expression of CHRM4 mRNA	11p11.2	A21555
Carmustine	Approved Investigational	CHRNB3	1142	downregulated	Carmustine results in decreased expression of CHRNB3 mRNA	8p11.21	A21555
Carmustine	Approved Investigational	CHRNG	1146	downregulated	Carmustine results in decreased expression of CHRNG mRNA	2q37.1	A21555
Carmustine	Approved Investigational	CKM	1158	downregulated	Carmustine results in decreased expression of CKM mRNA	19q13.32	A21555
Carmustine	Approved Investigational	CLTCL1	8218	upregulated	Carmustine results in increased expression of CLTCL1 mRNA	22q11.21	A21555
Carmustine	Approved Investigational	CNTNAP1	8506	upregulated	Carmustine results in increased expression of CNTNAP1 mRNA	17q21.2	A21555
Carmustine	Approved Investigational	COL9A1	1297	downregulated	Carmustine results in decreased expression of COL9A1 mRNA	6q13	A21555
Carmustine	Approved Investigational	COX6A2	1339	downregulated	Carmustine results in decreased expression of COX6A2 mRNA	16p11.2	A21555
Carmustine	Approved Investigational	CRABP1	1381	downregulated	Carmustine results in decreased expression of CRABP1 mRNA	15q25.1	A21555
Carmustine	Approved Investigational	CRAT	1384	downregulated	Carmustine results in decreased expression of CRAT mRNA	9q34.11	A21555
Carmustine	Approved Investigational	CRYBB1	1414	downregulated	Carmustine results in decreased expression of CRYBB1 mRNA	22q12.1	A21555
Carmustine	Approved Investigational	CST5	1473	downregulated	Carmustine results in decreased expression of CST5 mRNA	20p11.21	A21555
Carmustine	Approved Investigational	CTF1	1489	downregulated	Carmustine results in decreased expression of CTF1 mRNA	16p11.2	A21555
Carmustine	Approved Investigational	CTNNAL1	8727	upregulated	Carmustine results in increased expression of CTNNAL1 mRNA	9q31.3	A21555
Carmustine	Approved Investigational	CYP19A1	1588	downregulated	Carmustine results in decreased expression of CYP19A1 mRNA	15q21.2	A21555
Carmustine	Approved Investigational	CYTH1	9267	upregulated	Carmustine results in increased expression of CYTH1 mRNA	17q25.3	A21555
Carmustine	Approved Investigational	DHX16	8449	downregulated	Carmustine results in decreased expression of DHX16 mRNA	6p21.33	A21555
Carmustine	Approved Investigational	DNASE1L2	1775	downregulated	Carmustine results in decreased expression of DNASE1L2 mRNA	16p13.3	A21555
Carmustine	Approved Investigational	DTX2P1-UPK3BP1-PMS2P11	441263	downregulated	Carmustine results in decreased expression of DTX2P1-UPK3BP1-PMS2P11 mRNA	7q11.23	A21555
Carmustine	Approved Investigational	DVL1	1855	downregulated	Carmustine results in decreased expression of DVL1 mRNA	1p36.33	A21555
Carmustine	Approved Investigational	ECM2	1842	upregulated	Carmustine results in increased expression of ECM2 mRNA	9q22.31	A21555
Carmustine	Approved Investigational	EEF1G	1937	upregulated	Carmustine results in increased expression of EEF1G mRNA	11q12.3	A21555
Carmustine	Approved Investigational	EIF2B1	1967	upregulated	Carmustine results in increased expression of EIF2B1 mRNA	12q24.31	A21555
Carmustine	Approved Investigational	EIF6	3692	downregulated	Carmustine results in decreased expression of EIF6 mRNA	20q11.22	A21555
Carmustine	Approved Investigational	EPHX1	2052	downregulated	Carmustine results in decreased expression of EPHX1 mRNA	1q42.12	A21555

Displaying entries 16051 - 16075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability